H B Beverloo
Overview
Explore the profile of H B Beverloo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rack K, van den Berg E, Haferlach C, Beverloo H, Costa D, Espinet B, et al.
Leukemia
. 2020 Feb;
34(8):2262-2264.
PMID: 32042082
No abstract available.
2.
Rack K, van den Berg E, Haferlach C, Beverloo H, Costa D, Espinet B, et al.
Leukemia
. 2019 Jan;
33(8):1851-1867.
PMID: 30696948
Cytogenomic investigations of haematological neoplasms, including chromosome banding analysis, fluorescence in situ hybridisation (FISH) and microarray analyses have become increasingly important in the clinical management of patients with haematological neoplasms....
3.
Reedijk A, Klein K, Coebergh J, Kremer L, Dinmohamed A, de Haas V, et al.
Leukemia
. 2018 Dec;
33(6):1349-1359.
PMID: 30568171
Variation in survival of pediatric acute myeloid leukemia (pAML) over time and between Western European countries exists. The aim of the current study is to assess the progress made for...
4.
Cornelissen J, Versluis J, Passweg J, van Putten W, Manz M, Maertens J, et al.
Leukemia
. 2014 Nov;
29(5):1041-50.
PMID: 25428261
The preferred type of post-remission therapy (PRT) in patients with acute myeloid leukemia (AML) in first complete remission (CR1) is a subject of continued debate, especially in patients at higher...
5.
Aalbers A, van den Heuvel-Eibrink M, Baumann I, Beverloo H, Driessen G, Dworzak M, et al.
Blood Cancer J
. 2014 May;
4:e209.
PMID: 24786393
Immunosuppressive therapy (IST), consisting of antithymocyte globulin and cyclosporine A, is effective in refractory cytopenia of childhood (RCC), suggesting that, similar to low-grade myelodysplastic syndromes in adult patients, T lymphocytes...
6.
van der Veer A, van der Velden V, Willemse M, Hoogeveen P, Petricoin E, Beverloo H, et al.
Blood Cancer J
. 2014 Feb;
4:e181.
PMID: 24531445
No abstract available.
7.
Aalbers A, van der Velden V, Yoshimi A, Fischer A, Noellke P, Zwaan C, et al.
Leukemia
. 2013 Jun;
28(1):189-92.
PMID: 23807769
No abstract available.
8.
van Grotel M, de Hoog M, de Krijger R, Beverloo H, van den Heuvel-Eibrink M
Leuk Res
. 2012 Jun;
36(10):1249-54.
PMID: 22727506
Recently, according to the Hypereosinophilic Diseases Working Group of the International Eosinophil Society, six variants of hypereosinophilic syndrome have been proposed, i.e. (1) myeloproliferative, (2) lymphoproliferative, (3) idiopathic/undefined, (4) overlapping,...
9.
Buitenkamp T, Pieters R, Gallimore N, van der Veer A, Meijerink J, Beverloo H, et al.
Leukemia
. 2012 Mar;
26(10):2204-11.
PMID: 22441210
Children with Down's syndrome (DS) have an increased risk of developing acute lymphoblastic leukemia (ALL) and have a low frequency of established genetic aberrations. We aimed to determine which genetic...
10.
Corthals S, Sun S, Kuiper R, de Knegt Y, Broyl A, van der Holt B, et al.
Leukemia
. 2011 Jun;
25(11):1784-9.
PMID: 21701488
No abstract available.